
On Wednesday, pharmaceutical firm Lundbeck has released its full-year financial figures for 2021.
In connection with the report, Lundbeck has also showcased its 2022 outlook. The company hopes to end 2022 with a revenue of DKK 16.7–17.3bn (USD 2.56–2.65bn) and operating profits (EBIT) of DKK 2.2–2.6bn (USD 337.6–399m).
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app